Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Submitted by
admin
on August 6, 2013 - 10:00am
Source:
Seeking Alpha
News Tags:
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Headline:
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Do Not Allow Advertisers to Use My Personal information
